Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Breast Neoplasms 33 Neoplasms 25 Prostatic Neoplasms 16 Colorectal Neoplasms 13 Lung Neoplasms 11 Multiple Myeloma 9 Head and Neck Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Urinary Bladder Neoplasms 5 Hematologic Neoplasms 5 Gastrointestinal Neoplasms 5 Advanced Cancer 5 Uterine Cervical Neoplasms 4 Smoking Cessation 4 Ovarian Neoplasms 4 Melanoma 4 Leukemia 4 Colonic Neoplasms 4 Anxiety Disorders 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Recurrence 3 Rectal Neoplasms 3 Neoplasms, Plasma Cell 3 Motor Activity 3 Lymphoma, Follicular 3 Lymphedema 3

Interventions

Radiotherapy 6 Fibroblast Growth Factor 7 4 Injections 3 Drug Therapy 3 Cisplatin 3 Water 2 Propolis 2 Mouthwashes 2 Morphine 2 Methotrexate 2 Melphalan 2 Low-Level Light Therapy 2 Interleukin 1 Receptor Antagonist Protein 2 Gabapentin 2 Cryotherapy 2 peppermint oil 1 pegaspargase 1 oxycodone-acetaminophen 1 nelarabine 1 kang-lai-te 1 glucarpidase 1 fludarabine phosphate 1 fish oil triglycerides 1 cyclohexaneacetic acid 1 calcium phosphate 1 brilacidin 1 anise oil 1 amlexanox 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 acetaminophen, hydrocodone drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Mucositis × Standard of Care × Clear all

NCT01917942 2017-07-12

RadioHum

Trans Tasman Radiation Oncology Group

Phase 3 Completed

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡